|
Phenotype
|
Fish
|
Conditions
|
Figures
|
|
brain endothelial blood brain barrier broken, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 1
from Hu et al., 2025
|
|
whole organism kdr expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
intestine fabp1a expression spatial pattern, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 3
from Luo et al., 2019
|
|
whole organism dead, abnormal
|
ciao3ihb379/ihb379
|
control
|
Fig. S2,
Figure 3
from Hu et al., 2025
|
|
intestine fabp1a expression decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 3
from Luo et al., 2019
|
|
whole organism bmp7b expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
whole organism cellular respiration decreased process quality, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism Endothelin-1 increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism aconitate hydratase activity decreased process quality, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism lipid oxidation increased process quality, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2 ,
Figure 3
from Hu et al., 2025
|
|
whole organism cyp2n13 expression decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism lipid increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism gck expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
whole organism reactive oxygen species increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism deformed, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. S2
from Hu et al., 2025
|
|
whole organism cyp8b1.2 expression decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
blood vessel development hypertrophic growth, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
whole organism tek expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
whole organism bmp16 expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
whole organism lipid oxidation process characteristic, ameliorated
|
ciao3ihb379/ihb379
|
chemical treatment by environment: ferrostatin-1
|
Figure 3
from Hu et al., 2025
|
|
whole organism cyp2x7 expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
glutathione synthase activity decreased efficacy, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 4
from Luo et al., 2019
|
|
exocrine pancreas fabp2 expression spatial pattern, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 3
from Luo et al., 2019
|
|
blood vessel cyp2p8 expression decreased distribution, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism bmp2b expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
whole organism cyp3c3 expression decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism nitric oxide decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism cyp2p8 expression decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
aconitate hydratase activity decreased efficacy, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 1
from Luo et al., 2019
|
|
adenylyl-sulfate reductase (glutathione) activity decreased efficacy, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 4
from Luo et al., 2019
|
|
whole organism iron cation increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism viability, ameliorated
|
ciao3ihb379/ihb379
|
chemical treatment by environment: ferrostatin-1
|
Figure 3
from Hu et al., 2025
|
|
whole organism glutathione decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
blood vessel cyp2p8 expression spatial pattern, ameliorated
|
ciao3ihb379/ihb379
|
chemical treatment by environment: Ophiopogonin D
|
Figure 2
from Hu et al., 2025
|
|
superoxide dismutase activity decreased efficacy, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 4
from Luo et al., 2019
|
|
whole organism hkdc1 expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
liver ela2l expression spatial pattern, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 3
from Luo et al., 2019
|
|
whole organism hif1ab expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 4
from Luo et al., 2019
|
|
brain rough endoplasmic reticulum morphology, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 1
from Hu et al., 2025
|
|
blood vessel development hypertrophic growth, ameliorated
|
ciao3ihb379/ihb379
|
chemical treatment: 2-methoxy-17beta-estradiol
|
Fig. 5
from Luo et al., 2019
|
|
intestine hif1ab expression increased distribution, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 4
from Luo et al., 2019
|
|
whole organism cyp2k8 expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
digestive system compound organ morphology, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 3
from Luo et al., 2019
|
|
liver ela2l expression decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 3
from Luo et al., 2019
|
|
swimming behavior increased process quality, abnormal
|
ciao3ihb379/ihb379
|
control
|
Figure 1
from Hu et al., 2025
|
|
exocrine pancreas fabp2 expression decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 3
from Luo et al., 2019
|
|
whole organism pdgfrb expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
whole organism angpt1 expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
whole organism vegfab expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
whole organism glutamine decreased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
whole organism aldoca expression increased amount, abnormal
|
ciao3ihb379/ihb379
|
standard conditions
|
Fig. 5
from Luo et al., 2019
|
|
swimming behavior increased process quality, abnormal
|
ciao3ihb379/+
|
control
|
Figure 1
from Hu et al., 2025
|
|
whole organism nitric oxide decreased amount, abnormal
|
ciao3ihb379/ihb379; s843Tg
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
dorsal longitudinal anastomotic vessel disorganized, abnormal
|
ciao3ihb379/ihb379; s843Tg
|
standard conditions
|
Figure 1
from Hu et al., 2025
|
|
dorsal aorta deformed, abnormal
|
ciao3ihb379/ihb379; s843Tg
|
standard conditions
|
Figure 1
from Hu et al., 2025
|
|
lateral dorsal aorta blood circulation increased rate of continuous process, abnormal
|
ciao3ihb379/ihb379; s843Tg
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
posterior cardinal vein deformed, abnormal
|
ciao3ihb379/ihb379; s843Tg
|
standard conditions
|
Figure 1
from Hu et al., 2025
|
|
brain endothelial blood brain barrier broken, abnormal
|
ciao3ihb379/ihb379; s843Tg
|
standard conditions
|
Figure 1
from Hu et al., 2025
|
|
dorsal longitudinal anastomotic vessel decreased amount, abnormal
|
ciao3ihb379/ihb379; s843Tg
|
standard conditions
|
Figure 1
from Hu et al., 2025
|
|
whole organism Endothelin-1 increased amount, abnormal
|
ciao3ihb379/ihb379; s843Tg
|
standard conditions
|
Figure 2
from Hu et al., 2025
|
|
blood vessel development hypertrophic growth, abnormal
|
ciao3ihb379/ihb379; y1Tg
|
standard conditions
|
Fig. 2
from Luo et al., 2019
|